Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06026969 · ClinicalTrials.gov registry record
Pregnancy and Early Neurodevelopmental Outcomes Following In Utero Lyme Disease Exposure
A clinical trial of Pregnancy Complications and Child Development, sponsored by Children's National Research Institute.
- Recruiting
- Registry status
- 40
- Enrollment target
- 1
- Study location
NCT06026969: Recruiting study of Pregnancy Complications and Child Development, sponsored by Children's National Research Institute.
NCT06026969 is a study of Pregnancy Complications and Child Development that is actively recruiting participants, run by Children's National Research Institute. The registered enrollment target is 40 participants, below the 3,790-participant average among 39 other Pregnancy Complications trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06026969, a study of Pregnancy Complications and Child Development, is actively recruiting participants, sponsored by Children's National Research Institute.
- RECRUITING
- Registry status
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this pilot study is to assess the feasibility of longitudinal neurodevelopmental evaluation of fetuses and infants exposed to Lyme disease in utero. Participants with Lyme disease or Post-Treatment Lyme Disease Syndrome (PTLDS) will be recruited during pregnancy. Pregnancies will be monitored and infant development will be assessed from birth until age 18 months.
Primary Outcome
The primary outcome of this pilot study is to assess the feasibility of enrollment and longitudinal follow-up of Lyme-exposed dyads. Investigators will measure the number of parent-infant dyads who are eligible for participation, who participate in each study visit, and who successfully complete the study through infant age 18 months, throughout the duration of the study.
Conditions Studied
Interventions
- OTHER Neurodevelopmental assessments and follow-up
Study Locations (1)
District of Columbia
- Children's National Hospital - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2023-07-01 |
| Est. Completion | 2025-06 |
What NCT06026969 shows while recruiting
NCT06026969 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 3,790-participant average among 39 other Pregnancy Complications trials with a reported enrollment target (99% lower).
The record links to 6 conditions, with Pregnancy Complications appearing as the primary indexed condition, and to 1 intervention - of which Neurodevelopmental assessments and follow-up is the first listed.
NCT06026969 reports a single indexed study location in District of Columbia.
Frequently Asked Questions
What is clinical trial NCT06026969 about?
NCT06026969 is a clinical study titled "Pregnancy and Early Neurodevelopmental Outcomes Following In Utero Lyme Disease Exposure". The purpose of this pilot study is to assess the feasibility of longitudinal neurodevelopmental evaluation of fetuses and infants exposed to Lyme disease in utero. Participants with Lyme disease or Post-Treatment Lyme Disease Syndrome (PTLDS) will be recruited during pregnancy. Pregnancies will be m...
What is the current status of trial NCT06026969?
This trial is currently recruiting. The enrollment target is 40 participants. The study started on 2023-07-01. Estimated completion is 2025-06.
What conditions does trial NCT06026969 study?
This clinical trial studies the following conditions: Pregnancy Complications, Child Development, Lyme Disease, Post-Treatment Lyme Disease, Chronic Lyme Disease.
What interventions are being tested in trial NCT06026969?
The interventions under investigation include: Neurodevelopmental assessments and follow-up (OTHER).
Who is sponsoring clinical trial NCT06026969?
This trial is sponsored by Children's National Research Institute, which has 92 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06026969 being conducted?
This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pregnancy Complications
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06026969's enrollment target sits among peer trials
40 36th of 39 higher than 3 of 39 other Pregnancy Complications trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pregnancy Complications trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Resources, Inspiration, Support and Empowerment (RISE) for Black Pregnant Women
RECRUITING · Phase 2
-
Inhaled Insulin vs Rapid-acting Injections for Post-meal Glucose Control in Women With Gestational Diabetes
RECRUITING · Phase 2
-
Eliminating Severe Maternal Morbidity With Heart Health Doulas Trial
RECRUITING · NA
-
Treatment With Aspirin After Preeclampsia: TAP Trial
RECRUITING · Phase 4
-
Delivering HOPE (Helping Women Optimize Prenatal Equity)
RECRUITING · NA
-
Better Lifestyle Counseling for African American Women During Pregnancy
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI